Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children

Lin Guozhen; Liu Dongmei; Zhu Lin; Qiu Dingzhong

doi:10.1007/BF02970579

Your Location：

Home >

Browse articles >

Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children

OriginalPaper | Updated：2021-08-27

- Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children
- Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children
- 中国结合医学杂志（英文版） 2000年6卷第2期页码：116-118
- Affiliations：
  
  Affiliated Ruijin Hospital of Shanghai Second Medical University,Shanghai
- Author bio：
- Funds：
- DOI：10.1007/BF02970579
  中图分类号：
- 纸质出版日期：2000，
Scan for full text
Lin, G., Liu, D., Zhu, L. et al. Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children., CJIM 6, 116–118 (2000). https://doi.org/10.1007/BF02970579

Lin Guozhen, Liu Dongmei, Zhu Lin, et al. Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children[J]. Chinese Journal of Integrative Medicine, 2000,6(2):116-118.
Lin, G., Liu, D., Zhu, L. et al. Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children., CJIM 6, 116–118 (2000). https://doi.org/10.1007/BF02970579 DOI：

Lin Guozhen, Liu Dongmei, Zhu Lin, et al. Clinical Observation on Shuanghuanglian powder in treating viral myocarditis of childrenin treating viral myocarditis of children[J]. Chinese Journal of Integrative Medicine, 2000,6(2):116-118. DOI： 10.1007/BF02970579.

摘要

Objective: To study immune function of children viral myocarditis and to evaluate the clinical effect of Shuanghuanglian Powder (SHLP) by injection.Methods: The 62 patients of viral myocarditis were divided into two groups randomly

the SHLP group (n = 32) treated with conventional therapy plus SHLP and the conventional treatment group (n = 30) with conventional therapy alone. Their serum antibody of Coxsackie virus group B (COXB-IgM)

T-lymphocyte subsets including CD3 +

CD4 +

CD8 + and CD4 +/CD8 + were determined with ELISA and indirect immunofluorescent assay.Results: COXB-IgM was positive in 39 of the 62 patients

which was significantly different with those of normal controls (P< 0.001). Patients’ serum level of CD4 + cells and CD4 +/CD8 + ratio decreased while CD8 + increased. After treatment

the recovery of symptoms

signs and immune function in patients of the SHLP group were significantly better than those in patients treated with conventional treatment alone (P<0.01).Conclusion: Immunoregulatory disturbance is involved in children with viral myocarditis and SHLP is an effective drug in the treatment of children viral myocarditis.

Abstract

T-lymphocyte subsets including CD3 +

CD4 +

CD8 + and CD4 +/CD8 + were determined with ELISA and indirect immunofluorescent assay.Results: COXB-IgM was positive in 39 of the 62 patients

which was significantly different with those of normal controls (P< 0.001). Patients’ serum level of CD4 + cells and CD4 +/CD8 + ratio decreased while CD8 + increased. After treatment

the recovery of symptoms

关键词

Shuanghuanglian Powderinfantile viral myocarditisT-lymphocyte subsetCoxsackievirus group B antibody

Keywords

Shuanghuanglian Powderinfantile viral myocarditisT-lymphocyte subsetCoxsackievirus group B antibody

references

The cooperation group of nine provinces and one city in infantile myocarditis. Investigation on occurence of infantile myocarditis in nine provinces and one city. Chinese J Pediatrics. 1981; 19:62–63.

Schulze K, Schutheirs HP, Bolte HD, et al. Antibodies to ADP-ATP carrier — an autoantigen in myocarditis and dilated cardiomyopathy-impair cardiac function. Circulation 1990;81(3):959–961.

Guthrie M, Lodge PA, Huber SA. Cardiac injury in myocarditis induced by Coxsackie virus group B type 3. Cell Immunol 1984; 88:558–559.

Sun Yiping, Li Yufeng, Sun Xianping, et al. Observation on detecting of Coxsackievirus B antibody, T-lymphocyte subsets and erythrocyte immune in viral myocarditis. Clin J Pediatricsell. 1997; 15(3): 174–175.

Gao Haiquan. Pharmacology actions of drugs for clearing Heat and detoxication. Research on Chinese Patent Drugs. 1981;7:27–28.

FULL TEXT LINK

More>

浏览量

329

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Clinical Study on treatment of mid-late stage gastric carcinoma by compound Xiansu capsule ( ) combined with chemotherapy) combined with chemotherapy

Clinical and experimental study on huodan tablet in treating infantile viral myocarditis) in treating infantile viral myocarditis

Effect of Shenmai injection on cardiac function and cellular immunity of patients with infantile viral myocarditis) on cardiac function and cellular immunity of patients with infantile viral myocarditis